By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Contact Information

Website: www.fibrogen.com
Email: mtung@fibrogen.com
Main Phone: +1 415 978-1200
Address: 409 Illinois Street
State: CA
City / Town: San Francisco
Country: US
Postal Code: 94158

Issuer Information

Exchange: NGS
CEO: Enrique A. Conterno
Employees: 599
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A